Fortrea Holdings FTRE
NASDAQ FTRE
$20.29 +0.32 (+1.60%)
As of: Sep 17, 2026 · 3:59 PM EDT

Fortrea Holdings (FTRE) Capital Expenditures (2022 - 2026)

Fortrea Holdings' (FTRE) quarterly Capital Expenditures came in at $9.0 million in Q2 2026, up 20.0% on a YoY basis from $7.5 million in Q2 2025, and up 12.5% quarter-over-quarter from $8.0 million in Q1 2026.

Analysis

Fortrea Holdings (FTRE) Capital Expenditures (2022 - 2026) Analysis & Trends

Fortrea Holdings (FTRE) has reported Capital Expenditures for 5 consecutive years, with $9.0 million the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Capital Expenditures rose 20.0% year-over-year to $9.0 million; the trailing twelve-month figure through Jun 2026 stood at $31.8 million (up 106.49% YoY), and the FY2025 full-year result was $25.2 million, down 1.18% from the prior year.
  • Capital Expenditures improved to $9.0 million in Q2 2026 per FTRE's latest filing, from $8.0 million in the prior quarter.
  • Across five years, Capital Expenditures topped out at $18.4 million in Q4 2022 and bottomed at -$3.2 million in Q4 2024.
  • Historically, Capital Expenditures has averaged $9.0 million across 5 years, with a median of $8.6 million in 2024.
  • The sharpest annual moves came in 2024 and 2025: Capital Expenditures plunged 134.04% in 2024, then surged 334.38% in 2025.
  • Over 5 years, Capital Expenditures stood at $18.4 million in 2022, then sank by 48.91% to $9.4 million in 2023, then slumped by 134.04% to -$3.2 million in 2024, then soared by 334.38% to $7.5 million in 2025, then advanced by 20.0% to $9.0 million in 2026.
  • According to Business Quant data, Capital Expenditures over the past three periods registered $9.0 million, $8.0 million, and $7.5 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capital Expenditures (Qtr)
1 Iqvia Holdings 44.72 Bn 42.64 Bn 1.44 Bn 198.00 Mn
2 Medpace Holdings 17.37 Bn 16.87 Bn 201.64 Mn 23.91 Mn
3 Icon 13.65 Bn 12.72 Bn 479.29 Mn -42.42 Mn
4 Charles River Laboratories International 13.13 Bn 12.94 Bn 452.07 Mn 31.11 Mn
5 Fortrea Holdings 1.89 Bn 1.72 Bn 139.20 Mn 9.00 Mn
6 Evotec SE 574.75 Mn 148.87 Mn - -
7 Ginkgo Bioworks Holdings 439.63 Mn 355.09 Mn 18.44 Mn 2.62 Mn
8 Champions Oncology 69.43 Mn 65.03 Mn 7.70 Mn 125,000.00
9 MindWalk Holdings 51.76 Mn 46.29 Mn 1.61 Mn -55,941.69
10 VivoSim Labs 1.37 Mn 1.37 Mn - 23,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 9.00 Mn
Mar 31, 2026 8.00 Mn
Dec 31, 2025 7.50 Mn
Sep 30, 2025 7.30 Mn
Jun 30, 2025 7.50 Mn
Mar 31, 2025 2.90 Mn
Dec 31, 2024 -3.20 Mn
Sep 30, 2024 8.20 Mn
Jun 30, 2024 11.20 Mn
Mar 31, 2024 9.30 Mn
Dec 31, 2023 9.40 Mn
Sep 30, 2023 5.10 Mn
Jun 30, 2023 9.60 Mn
Mar 31, 2023 16.20 Mn
Dec 31, 2022 18.40 Mn
Sep 30, 2022 17.00 Mn